BÉKÁSI Tamás

RIS Business Creation Project Manager, EIT Health InnoStars, Budapest

In the past 15 years, Tamás Békási acquired wide scale knowledge in process and business development, marketing communication and international service transfer, while he worked in the agency, corporate and SSC sector. As Business Creation Project Manager for the RIS Region in EIT Health, his top priority is to support and mentor european healthcare professionals from the ideation phase, through the market entry, to the global expansion.

BEN AMI Doron

CEO ShizimXL

Mr. Doron Ben Ami is a highly experienced executive with a successful track record of more than 20 years of in the biotech industry. He previously held a range of executive positions including Associate Vice President for the Eastern European and Israel region at Merck (MSD), Managing Director of the Merck subsidiary in Israel, and General Manager of Lundbeck Israel. Founder of Triticum, a startup company that is developing a clot retriever device for the treatment of stroke and occlusions in peripheral vessels. Acts as a consultant to pharma and medical device companies. He earned a Master of Health Systems Administration degree (M.H.A.) from Tel Aviv University, Israel.

BORNSTEIN Yossi

Founder, CEO of Shizim Group

CEO and the founder of Shizim, a life science holding company; Founder & Chairman of ShizimXL an international medical devices Innovation centers; Chairman of GCP Clinical Studies Ltd., one of the top provider of clinical research services and educational programs in Israel; served as the Biotechnology Committee Chairman of the United States-Israel Science & Technology Commission (the “USISTF”); founder of ILSI - Israel Life Science Industry Organization (who was integrated into IATI) and Founder of ITTN - Israel Tech Transfer Organization; Co-Founder and director of Microbot Medical (NASDAQ-MBOT) and a Co-Founder and a Director of XACT Robotics.

BRONCEL Adam

Poland Ventures, Managing Partner

CIEŚLAK Marek

CEO, BIONANOPARK Science and Technology Park

Learn More

CIMOSZKO SKOWRONSKI Boguslawa (Bogy)

Board Member, MIT Enterprise Forum Central & Eastern Europe

Learn More

DARVISH Nissim

Senior Managing Director at OrbiMed Advisors

DASTYCH Jarosław

CEO, Proten Pharmaceuticals

EMILEWICZ Jadwiga

Minister of Entrepreneurship and Technology

FERNANDEZ Tania

Founder & CEO, DreamCatcher Ventures

Learn More

GADOT Harel

Company Group Chairman; MEDX Ventures Group CEO; Microbot Medical, INC Nasdaq: MBOT

Learn More

GAJOWNIK Magda

Manager in Innovation Development Department at Polish Development Fund

She is responsible for creating new support measures for innovative individuals and companies. Currently she leads on PFR BioMed Academy programme dedicated to companies from medical and pharmaceutical sectors.

GAWIN Dariusz

Professor and Vice-rector of the Innovation and Development of the Lodz University of Technology

Dariusz Gawin - professor of technical sciences, full professor and Vice-rector of innovation and development of the Lodz University of Technology in the 2016-2020, in the 2008–2016 Dean of the Faculty of Civil Engineering, Architecture and Environmental Engineering of the Lodz University of Technology. Member of the Committee for Civil Engineering of the Polish Academy of Sciences.
Member of the Board of Bionanopark since 2017.

GENSIOR Sebastian

Managing Director of Global Health Access Solutions

Sebastian is the managing director of Global Health Access Solutions, where he provides clients with market insights and go-to-market strategies. Over the past seven years, he held multiple market access and health policy positions in the pharmaceutical industry, most notably at Roche and Edelman. He has supported pharmaceutical and medical devices clients in understanding healthcare markets around the world and was actively involved in healthcare reforms. Sebastian is continuously exploring innovative pricing and market access solutions to bring innovations to patients. He holds a Bachelor in European Public Health from the University of Maastricht.

GROBELSKI Bartłomiej

Medical University of Lodz, Director of the Centre for Innovation and Technology Transfer

Learn More

GURDAŁA Mikołaj

Director of Innovation in the Northern and Central European Region, EIT Health InnoStars

Learn More

JAROS Sławomir

Member of the Board and CSO, COO, Mabion

Sławomir Jaros, PhD, Eng, EMBA

Graduated from the Warsaw University of Life Sciences with a major in biotechnology. He obtained his PhD in biology at the Polish Academy of Sciences in Warsaw. He completed the Polish-American Executive MBA Studies conducted jointly by the University of Maryland and the University of Lodz.
He engaged in many biotech projects – including the creation of recombinant proteins and vaccines. Sławomir Jaros has been associated with Mabion since late 2007 and his responsibilities include the development of technology and Mabion products.
In 2015, Sławomir Jaros was chosen as one of the 10 best among the youngest members of management boards in big companies listed at the Warsaw Stock Exchange.

JAROSZ Jerzy

Director of Science and Education Center and Chairman of Observatory Responsible Pain Treatment, St. Christopher Oncological Hospice in Warsaw

Director of Science and Education Center and Chairman of Observatory Responsible Pain treatment in St. Christopher Oncological Hospice in Warsaw. Founder of the First in Poland Medical Marijuana Consultation Point.

KĘDRA Piotr

Investment Director, PFR Ventures sp. z o.o

From the beginning of his professional career associated with the transaction market, he worked in private equity funds, has managerial experience in operating companies. In 1995-2000 he worked as an investment analyst at Enterprise Investors, the oldest private equity fund operating in Poland and Central Europe, then in 2000-2011 at Advent International, one of the leading global private equity funds, as a director. He participated in a number of transactions in various sectors (including Radio Zet, Bolix, Slag Recycling, WSiP, Polish-American Heart Clinics), on the private and public market, he also represented the interests of funds in supervisory boards. In the years 2012-2019 as the director of strategic projects at WSiP, a leading provider and educational services, and at the same time a member of the management board of the subsidiary, Zielona Sowa, coordinated the development and implementation of strategies in the field of digitization and expansion of the segment of products and services on the non-school market. He carried out a number of acquisitions of companies or product portfolios (including the largest networks of language schools Profi-Lingua and Empik School) and operational integration of acquired businesses, implemented strategic partnerships with global companies (including Pearson and Disney), as well as oversaw the development new activities within the group.

He graduated in 1996 in finance and banking from the Faculty of Economics of the University of Warsaw and is a graduate of the combined Columbia University School of International and Public Affairs (SIPA, New York) and the University of Warsaw.

KLEINA Artur

CEO, Bio-Gen

Advanced industrial biotechnologist with 5 years of experience in manufacturing microorganisms, creating agriculture use products, quality control and company managing. Focus on application biology in farming, environment protection, research and developing a new type of microbiological products.

KONECKI Tomasz

Salve Medica

KUC Włodzimierz

Director at the Department for R&D Investments, NCBR

A graduate of Law and Psychology at the Jagiellonian University in Cracov. He also studied International Relations and Law at Durham University in Great Britain. Moreover, he graduated from the School of American Law conducted by lecturers of The Catholic University of America, Columbus Scool of Law, Washington D.C. For the last few years he has been cooperating with the National Centre of Research and Development, currently responsible for implementing financial instruments dedicated to technology start-ups.

LACHOWSKI Slawomir

Chairman & CEO, G-Rock Ltd

MATAN Avi

General Manager, Poland, Novartis Oncology

Medical doctor by education, graduated from the Tel Aviv University. In addition, he holds an Executive M.B.A degree from the Bar Ilan University in Israel.
Prior joining Novartis, Avi worked in several start-up medical device companies as a medical director and in various commercial positions. During the last 15 years working for Novartis, he held various positions, both in medical and commercials roles across different divisions (Pharma & Oncology) and in various markets. For the last 3 years, Avi is leading the Polish team as the GM of Novartis Oncology in Poland, where he is located with wife and 3 kids. Avi is known as a leader with passion to help people develop and grow.

MICHALIK Marek

President of the Board in Lodz Special Economic Zone

MUSIAŁEK Jakub

CEO of Pixel Technology, CEO of UnitDoseOne (since 2012)

Learn More

NAWRAT Zbigniew

President of the International Society of Medical Robotic

Learn More

OPHIR Yael

Executive Director, HealthIL

Learn More

PAMPUCH Bartosz

CEO, Comarch Healthcare

PARDO Tamir

Chairman of Shizim Group, the Former Director of the Mossad

PUSTELNIK Adam

Advisor to the Mayor of the City of Łódź for Economic Development

RIESKE Piotr

CSO, Celther; CEO, Personather

Piotr Rieske is a co-founder of Celther Polska LTD and Personather LTD. He studied at the Faculty of Medical Analytics, Pharmacy, Medical Academy of Lodz (1991-1996). He received PhD title in 1998 at the Medical Academy of Lodz. From 1999-2005 he was on internships in the USA (Universities: Jefferson, Hahnemann, Temple). In 2006 he received a postdoctoral degree (PhD habilitation). Since 2010 he is CTO of Celther Polska. Since 2012 he has been managing the Tumor Biology Department at the Medical University of Lodz. In 2013 he received professor title. He is an author of more than seventy peer-reviewed scientific publications (stem cell research, molecular oncology). He is an inventor of almost twenty patents and patents applications (regenerative medicine, anticancer therapies).

SADILEK Tomas

Director of Governmental Affairs, ICCI (International Cannabis and Cannabinoids Institute)

Learn More

SCHLATMANN Reinier

CEO of Philips Central and Eastern Europe

Learn More

STOLAR Orit

Pediatric Neurologist, Autism Center of Alut, Shamir Medical Center, Israel

SURACE Filippo

Founder and CEO at Cube-Labs a Life Sciences Incubator and Accelerator

Learn More

SZALOKI Katalin

Public Affairs Lead, EIT Health InnoStars

Katalin Szalóki, PhD, is the Public Affairs Executive at EIT Health Innostars. In this capacity Ms. Szalóki deals with public affairs as well as PR tasks of EIT Health Innostars. Besides representing EIT Health Innostars and developing (RIS) regions towards third parties, she is working on the creating of sustainable financing scheme for the community and interconnection of financial resources.
In her previous roles coming from the field of diplomacy, she had been working with European Union affairs for more than 15 years. This period included Hungary joining the European Union and also the very first Hungarian EU Presidency. She served as the Head of the Permanent Representation to the EU of the Hungarian National Assembly in Brussels and for more than a decade she has been supporting the enhancement of EU related activities of various legislative bodies in the Western Balkan region.
Her passion connects healthcare and medical issues with EU in order to provide channel for European healthcare innovators to show the best of their knowledge to the world.

WIAK Sławomir

Rector of the Technical University of Lodz

Learn More

WOZNIAK Lucyna

Vice-Rector Medical University of Lodz

YOSEFI Ariel

Partner, Co-Head of Technology & Regulation Department, Herzog Fox & Neeman

ZIEŃ Piotr

Innovation and Science Director, Polpharma Biologics

Learn More